MicroCor® Transdermal Delivery System: A Safe, Efficient, and Convenient Transdermal System for Vaccine Administration
The development of convenient, safe, efficient, and effective delivery methods for large molecular weight drugs (including biologicals and vaccines) by non-parenteral administration routes continues to be an objective for a number of academic institutions and commercial organizations. Transdermal delivery of drugs is generally limited to small and potent molecules using conventional patch technology and passive diffusion mechanisms. Large molecular weight drugs are generally administered by intramuscular or subcutaneous routes of administration using the traditional needle and syringe, or in some cases using needle-less injector devices. Fear and pain are universal concerns in needle-based drug delivery, particularly in the pediatric population, and can make the experience of vaccination rather unpleasant. “Needle-phobia” is one of the major reasons for vaccine noncompliance, which can lead to less than optimal therapeutic outcomes. Noncompliance also contributes significantly to the direct and indirect economic burden on the patient and the health-care system.
KeywordsResidual Drug Backing Layer Inactive Ingredient Drug Layer Passive Diffusion Mechanism
The authors would like to acknowledge the Corium team for their various efforts towards developing the MicroCor technology platform and products. The authors would also like to gratefully acknowledge Raymond Daynes of the University of Utah for collaborating on the rPA studies.
- 9.Draize JH (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 83:377–390Google Scholar